Faculty profile

Taila Hartley

ResearcherUniversity of Ottawa

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Ottawa directory, so their courses and email address may be missing. Find their university profile.

Taila Hartley

Researcher

Health Sciences

University of Ottawa

Ottawa, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
28 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2023.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

230

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Clinical Genetics Clinical Practice Guidelines Economic Impact Genomics Health Outcomes Knowledge Mobilization Knowledge Synthesis Qualitative Interviews

Latest papers

A comprehensive approach to evaluating the clinical utility of genome sequencing in rare disease: A large prospective Canadian cohort.
Genetics in medicine : official journal of the American College of Medical Genetics · 2026
Diagnostic Utility of Exome Data Reanalysis After In Silico Multi-Gene Panels or Clinical Exome Testing for Patients With Epilepsy and Developmental Delay/Intellectual Disability: A Retrospective Cohort Study.
Clinical genetics · 2026
Clinical utility of exome sequencing: Post-exome testing decision changes in the management of children with suspected rare genetic disease.
Genetics in medicine : official journal of the American College of Medical Genetics · 2026

All 84 publications

Latest funding

A Canadian knowledge-to-action roadmap for evidence-informed implementation of first-tier clinical genome-wide sequencing for rare disease (K2A-RD)
CIHR · 2023 · Principal investigator
$1,374,619

All 1 grants and awards

84 publications.

A comprehensive approach to evaluating the clinical utility of genome sequencing in rare disease: A large prospective Canadian cohort.

Shickh S, Fooks K, Venkataramanan V, Acker M, MacDonald KV, Seeger TA, Gillespie M, Hartley T, Care4Rare Canada Consortium, Boycott KM, Bernier F, Marshall DA, Hayeems RZ

Genetics in medicine : official journal of the American College of Medical Genetics2026

DOI: 10.1016/j.gim.2026.101684 PMID: 41527898

Diagnostic Utility of Exome Data Reanalysis After In Silico Multi-Gene Panels or Clinical Exome Testing for Patients With Epilepsy and Developmental Delay/Intellectual Disability: A Retrospective Cohort Study.

Cuillerier A, Goodman A, Lawrence C, Villeneuve-Cloutier N, Armour CM, Bhola PT, Bourque DK, Carter MT, Lazier J, Sawyer SL, Saleh M, Prasad C, Siu VM, Care4Rare Canada Consortium, Boycott KM, Hartley T, Dyment DA, Balci TB

Clinical genetics2026

DOI: 10.1111/cge.70008 PMID: 40545823

Clinical utility of exome sequencing: Post-exome testing decision changes in the management of children with suspected rare genetic disease.

Tagimacruz T, Seeger TA, Degeling K, Fooks K, Venkataramanan V, Bernier FP, Boycott KM, Mendoza-Londono R, Hartley T, Hayeems RZ, Marshall DA, Care4Rare Canada

Genetics in medicine : official journal of the American College of Medical Genetics2026

DOI: 10.1016/j.gim.2026.102626 PMID: 42273873

Genetic data sharing by clinical laboratories in Canada: A position statement by the Canadian College of Medical Geneticists.

Lerner-Ellis J, Fisher Y, Zawati MH, Agatep R, Antonishyn N, Bosdet I, Boycott KM, King I, Lamont RE, Marshall CR, Martinez VD, Nelson TN, O'Rielly D, Yip S, Shantz B, Herscovich A, Price EM, Canadian College of Medical Geneticists,, Hartley T, Chun K

American journal of human genetics2026Senior author

DOI: 10.1016/j.ajhg.2026.09.001 PMID: 42772292

TRIAGE-GS: protocol for a randomised controlled trial of a genomics-first approach to rare disease diagnosis for patients awaiting assessment by a clinical geneticist.

Stanley KJ, Chisholm C, Gillespie MK, Caluseriu O, Del Signore N, Elango S, Hartley T, Hewson S, Kim RH, McSheffrey G, Mendoza-Londono R, Sawyer SL, Somerville M, Venkataramanan V, White-Brown A, Telesca S, Shickh S, Marshall CR, Ungar WJ, Hayeems RZ, Bhawra J, Boycott KM, Costain G

BMJ open2025

DOI: 10.1136/bmjopen-2025-107603 PMID: 40784761

Mainstreaming of clinical genetic testing: A conceptual framework.

Mackley MP, Richer J, Guerin A, Caluseriu O, Armstrong L, Blood KA, Bernier F, Boswell-Patterson C, Chard M, Costain G, Dyment D, Eaton A, Faghfoury H, Frosk P, Gillespie MK, Goh ES, Hayeems RZ, Hashemi B, Innes AM, Jackson M, Laberge AM, Limoges J, Marshall C, McMillan H, Nelson TN, Osmond M, Parboosingh J, Penney L, Prince B, Sawyer SL, Siu VM, Thomas MA, Turner L, Villeneuve-Cloutier N, Hartley T, Boycott KM

Genetics in medicine : official journal of the American College of Medical Genetics2025

DOI: 10.1016/j.gim.2025.101465 PMID: 40417744

Exome Sequencing in the Diagnostic Pathway for Suspected Rare Genetic Diseases: Does the Order of Testing Affect its Cost-Effectiveness?

Degeling K, Tagimacruz T, MacDonald KV, Seeger TA, Fooks K, Venkataramanan V, Boycott KM, Bernier FP, Mendoza-Londono R, Hartley T, Hayeems RZ, Marshall DA, Care4Rare Canada

Applied health economics and health policy2025

DOI: 10.1007/s40258-024-00936-7 PMID: 39739296

Leveraging cancer mutation data to inform the pathogenicity classification of germline missense variants.

Haque B, Cheerie D, Pan A, Curtis M, Nalpathamkalam T, Nguyen J, Salhab C, Thiruvahindrapuram B, Zhang J, Couse M, Hartley T, Morrow MM, Price EM, Walker S, Malkin D, Roth FP, Costain G

PLoS genetics2025

DOI: 10.1371/journal.pgen.1011540 PMID: 39761285

One-Sided Matching Portal (OSMP): A Tool to Facilitate Rare Disease Patient Matchmaking.

Osmond M, Price EM, Buske OJ, Frew M, Couse M, Hartley T, Klamann C, Le HGBH, Xu J, So D, Jain A, Lu K, Mo K, Wyllie H, Wall E, Driver HG, Cheung WA, Cohen ASA, Farrow EG, Thiffault I, Consortium CRC, Turinsky AL, Pastinen T, Brudno M, Boycott KM

Human mutation2025

DOI: 10.1155/humu/5941599 PMID: 41103356

Evaluation of the diagnostic accuracy of exome sequencing and its impact on diagnostic thinking for patients with rare disease in a publicly funded health care system: A prospective cohort study

Hartley T, Marshall D, Acker M, Fooks K, Gillespie MK, Price EM, Graham ID, White-Brown A, MacKay L, Macdonald SK

Genetics in Medicine202410 citationsFirst author

DOI: 10.1016/j.gim.2023.101012

Something wrong or missing on this profile? Suggest a correction

Taila Hartley

Research

Latest papers

Latest funding

A comprehensive approach to evaluating the clinical utility of genome sequencing in rare disease: A large prospective Canadian cohort.

Diagnostic Utility of Exome Data Reanalysis After In Silico Multi-Gene Panels or Clinical Exome Testing for Patients With Epilepsy and Developmental Delay/Intellectual Disability: A Retrospective Cohort Study.

Clinical utility of exome sequencing: Post-exome testing decision changes in the management of children with suspected rare genetic disease.

Genetic data sharing by clinical laboratories in Canada: A position statement by the Canadian College of Medical Geneticists.

TRIAGE-GS: protocol for a randomised controlled trial of a genomics-first approach to rare disease diagnosis for patients awaiting assessment by a clinical geneticist.

Mainstreaming of clinical genetic testing: A conceptual framework.

Exome Sequencing in the Diagnostic Pathway for Suspected Rare Genetic Diseases: Does the Order of Testing Affect its Cost-Effectiveness?

Leveraging cancer mutation data to inform the pathogenicity classification of germline missense variants.

One-Sided Matching Portal (OSMP): A Tool to Facilitate Rare Disease Patient Matchmaking.

Evaluation of the diagnostic accuracy of exome sequencing and its impact on diagnostic thinking for patients with rare disease in a publicly funded health care system: A prospective cohort study

A Canadian knowledge-to-action roadmap for evidence-informed implementation of first-tier clinical genome-wide sequencing for rare disease (K2A-RD)

Frequent collaborators

Jacek Majewski

Jodi Warman Chardon

Kristin Kernohan

Michael Brudno

Mark Tarnopolsky

Gregory Costain

Olga Jarinova

Francois Bernier

David Dyment

Bekim Sadikovic

Peter Kannu

Bernard Brais

Daniela Pohl

Rosanna Weksberg

David Chitayat

Ronald Cohn

John Woulfe

Gail Graham

Gerd Melkus

Lauren Chad

Michael Brudno

Bernard Brais

Beth Potter

Christina Honeywell

Eva Tomiak

Jean Michaud

Jocelyn Zwicker

Michael Geraghty

Tracy Stockley

Jasmin Bhawra

Jacqueline Limoges

Guy Rouleau